» Articles » PMID: 30015560

Role of Glycosylation in Hypoxia-driven Cell Migration and Invasion

Overview
Journal Cell Adh Migr
Specialty Cell Biology
Date 2018 Jul 18
PMID 30015560
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia, a common condition of the tumor microenvironment, induces changes in the proteome of cancer cells, mainly via HIF-1, a transcription factor conformed by a constitutively expressed β-subunit and an oxygen-regulated α-subunit. In hypoxia, HIF-1α stabilizes, forms the heterodimeric complex with HIF-1β, and binds to Hypoxia Response Elements (HRE), activating gene expression to promote metabolic adaptation, cell invasion and metastasis. Furthermore, the focal adhesion kinase, FAK, is activated in hypoxia, promoting cell migration by mechanisms that remain unclear. In this context, integrins, which are glycoproteins required for cell migration, are possibly involved in hypoxia-induced FAK activation. Evidence suggests that cancer cells have an altered glycosylation metabolism, mostly by the expression of glycosyltransferases, however the relevance of glycosylation is poorly explored in the context of hypoxia. Here, we discuss the role of hypoxia in cancer, and its effects on protein glycosylation, with emphasis on integrins and cell migration.

Citing Articles

Hypoxia-induced TPC2 transcription and glycosylation aggravates pulmonary arterial hypertension by blocking autophagy flux.

Li C, Li C, Jiang Y, Liu M, Yang C, Lu J Sci Rep. 2024; 14(1):31223.

PMID: 39732974 PMC: 11682160. DOI: 10.1038/s41598-024-82552-y.


Hypoxia-Induced Adaptations of N-Glycomes and Proteomes in Breast Cancer Cells and Their Secreted Extracellular Vesicles.

Peng B, Bartkowiak K, Song F, Nissen P, Schluter H, Siebels B Int J Mol Sci. 2024; 25(18).

PMID: 39337702 PMC: 11432262. DOI: 10.3390/ijms251810216.


Tumor glucose metabolism and the T cell glycocalyx: implication for T cell function.

Schuurmans F, Wagemans K, Adema G, Cornelissen L Front Immunol. 2024; 15:1409238.

PMID: 38881904 PMC: 11176483. DOI: 10.3389/fimmu.2024.1409238.


PRMT5 facilitates angiogenesis and EMT via HIF-1α/VEGFR/Akt signaling axis in lung cancer.

Zheng Y, Ji H, Yi W, Chen Z, Hu X, Zhou J Aging (Albany NY). 2023; 15(13):6163-6178.

PMID: 37400960 PMC: 10373979. DOI: 10.18632/aging.204826.


A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer.

Xu X, Wu Y, Jia G, Zhu Q, Li D, Xie K J Ovarian Res. 2023; 16(1):5.

PMID: 36611197 PMC: 9826597. DOI: 10.1186/s13048-022-01088-9.


References
1.
Keely S, Glover L, MacManus C, Campbell E, Scully M, Furuta G . Selective induction of integrin beta1 by hypoxia-inducible factor: implications for wound healing. FASEB J. 2008; 23(5):1338-46. PMC: 2669428. DOI: 10.1096/fj.08-125344. View

2.
Paul N, Jacquemet G, Caswell P . Endocytic Trafficking of Integrins in Cell Migration. Curr Biol. 2015; 25(22):R1092-105. DOI: 10.1016/j.cub.2015.09.049. View

3.
Semel A, Seales E, Singhal A, Eklund E, Colley K, Bellis S . Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors. J Biol Chem. 2002; 277(36):32830-6. DOI: 10.1074/jbc.M202493200. View

4.
Dozynkiewicz M, Jamieson N, MacPherson I, Grindlay J, van den Berghe P, von Thun A . Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression. Dev Cell. 2011; 22(1):131-45. PMC: 3507630. DOI: 10.1016/j.devcel.2011.11.008. View

5.
Wickstrom S, Alitalo K, Keski-Oja J . Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res. 2002; 62(19):5580-9. View